title: Enteroviral meningoencephalitis as complication of Rituximab therapy in a patient treated for diffuse large B-cell lymphoma.
authors.forename: Sophie
authors.initials: S
authors.lastname: Servais
authors.forename: Jo
authors.initials: J
authors.lastname: Caers
authors.forename: Odile
authors.initials: O
authors.lastname: Warling
authors.forename: Nicolas
authors.initials: N
authors.lastname: Frusch
authors.forename: Frédéric
authors.initials: F
authors.lastname: Baron
authors.forename: Bernard
authors.initials: B
authors.lastname: De Prijck
authors.forename: Yves
authors.initials: Y
authors.lastname: Beguin
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000009:adverse effects*; D004769:Enterovirus Infections / Q000139:chemically induced*; D005260:Female; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy*; D008279:Magnetic Resonance Imaging; D008590:Meningoencephalitis / Q000139:chemically induced*; D008875:Middle Aged; D009894:Opportunistic Infections / Q000139:chemically induced; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab